[
  {
    "id": 1,
    "title": "A Study in Joint Pain Discomfort ",
    "participants": "Joint Pain Participants",
    "description": "This is a Phase 1, clinical trial for joint pain that will be performed in San Francisco. This study will enroll a sufficient number of participants to see  any side effects realted to joint pain medicine.",
    "eligibility": [
      {
        "eligible": [
          {
            "requirement_one": "21 and older",
            "requirement_two": "Allergy Test Required",
            "requirement_three": "Joint pain",
            "requirement_four": "Gender Neutral"
          }
        ],
        "ineligible": [
          {
            "requirement_one": "Drug Allergies",
            "requirement_two": "Person without joint pain"
          }
        ]
      }
    ],
    "prerequisite": [
      { "requirement_one": "Must have Allergic Test Reaction test completed" }
    ],
    "detail": [
      {
        "_id": "FT10250014",
        "payout": "70",
        "status": "Not Recruiting",
        "study-type": "Observational",
        "start-date": "1/10/2023",
        "end-date": "10/10/2023",
        "last-updated": "10/10/2021"
      }
    ],
    "location": [
      {
        "address": "1001 Potrero Ave, San Francisco, CA 94110",
        "coordinates": [-122.4591373, 37.7365308]
      }
    ]
  },
  {
    "id": 2,
    "title": "Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia ",
    "participants": "Primary Immune, Thrombocytopenia",
    "description": "This is a Phase 2, open-label, single arm, multicenter, multiple subcutaneous injection, safety and efficacy study of PF-06835375",
    "eligibility": [
      {
        "eligible": [
          {
            "requirement_one": "18 - 70 years ",
            "requirement_two": "Primary Immune",
            "requirement_three": "Thrombocytopenia",
            "requirement_four": "Gender Neutral"
          }
        ],
        "ineligible": [
          {
            "requirement_one": "Non-Primary Immune",
            "requirement_two": "Non-Thrombocytopenia"
          }
        ]
      }
    ],
    "prerequisite": [
      { "requirement_one": "Must have Allergic Test Reaction test completed" }
    ],
    "detail": [
      {
        "_id": "FT10250015",
        "payout": "70",
        "status": "Not Recruiting",
        "study-type": "Interventional",
        "start-date": "12/15/2023",
        "end-date": "4/10/2024",
        "last-updated": "11/10/2021"
      }
    ],
    "location": [
      {
        "address": "2356 Sutter St, San Francisco, CA 94115",
        "coordinates": [-122.4415068, 37.7854709]
      }
    ]
  },
  {
    "id": 3,
    "title": "Real-World Effectiveness of Tafamidis on Neurologic Disease Progression in Patients ",
    "participants": "Hereditary Transthyretin Amyloidosis (ATTRv)",
    "description": "This will be an observational, retrospective cohort study using structured secondary anonymized data. Patients with mixed-phenotype ATTRv-CM receiving high dose tafamidis for at least 12 months will be identified.",
    "eligibility": [
      {
        "eligible": [
          {
            "requirement_one": "ATTRv",
            "requirement_two": "18+ years",
            "requirement_three": "Negative ATTRv ",
            "requirement_four": "Gender Neutral"
          }
        ],
        "ineligible": [
          {
            "requirement_one": "Positive ATTRv "
          }
        ]
      }
    ],
    "prerequisite": [
      { "requirement_one": "Must have negative ATTRv test reaction" }
    ],
    "detail": [
      {
        "_id": "FT10250016",
        "payout": "60",
        "status": "Not Recruiting",
        "study-type": "Observational",
        "start-date": "02/15/2023",
        "end-date": "7/10/2023",
        "last-updated": "10/15/2021"
      }
    ],
    "location": [
      {
        "address": "1001 Potrero Ave, San Francisco, CA 94110",
        "coordinates": [-122.4591373, 37.7365308]
      }
    ]
  },
  {
    "id": 4,
    "title": "ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer",
    "participants": "Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer",
    "description": "This Phase 2, open label, study with safety lead in of oral talazoparib in combination with ZEN003694 given daily in 28-day cycles will enroll patients with recurrent ovarian, fallopian tube or primary peritoneal carcinoma.",
    "eligibility": [
      {
        "eligible": [
          {
            "requirement_one": "Cancers listed above",
            "requirement_two": "18+ years",
            "requirement_three": "Female",
            "requirement_four": "ZEN003694"
          }
        ],
        "ineligible": [
          {
            "requirement_one": "Men"
          }
        ]
      }
    ],
    "prerequisite": [{ "requirement_one": "Must have  listed above cancers" }],
    "detail": [
      {
        "_id": "FT10250017",
        "payout": "90",
        "status": "Not Recruiting",
        "study-type": "Interventional",
        "start-date": "03/20/2023",
        "end-date": "8/10/2023",
        "last-updated": "09/15/2021"
      }
    ],
    "location": [
      {
        "address": "2356 Sutter St, San Francisco, CA 94115",
        "coordinates": [-122.4415068, 37.7854709]
      }
    ]
  },
  {
    "id": 5,
    "title": "Korean Regulatory Post Marketing Surveillance for Somavert",
    "participants": "Acromegaly",
    "description": "Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)",
    "eligibility": [
      {
        "eligible": [
          {
            "requirement_one": "Acromegaly",
            "requirement_two": "Any age",
            "requirement_three": "Gender Neutral",
            "requirement_four": "Korean "
          }
        ],
        "ineligible": [
          {
            "requirement_one": "Non-Korean"
          }
        ]
      }
    ],
    "prerequisite": [{ "requirement_one": "Korean RMP" }],
    "detail": [
      {
        "_id": "FT10250018",
        "payout": "90",
        "status": "Not Recruiting",
        "study-type": "Observational",
        "start-date": "01/20/2023",
        "end-date": "05/10/2023",
        "last-updated": "10/15/2021"
      }
    ],
    "location": [
      {
        "address": "1001 Potrero Ave, San Francisco, CA 94110",
        "coordinates": [-122.4591373, 37.7365308]
      }
    ]
  },
  {
    "id": 6,
    "title": "Korean Regulatory Post Marketing Surveillance for Somavert",
    "participants": "Acromegaly",
    "description": "Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)",
    "eligibility": [
      {
        "eligible": [
          {
            "requirement_one": "Acromegaly",
            "requirement_two": "Any age",
            "requirement_three": "Gender Neutral",
            "requirement_four": "Korean "
          }
        ],
        "ineligible": [
          {
            "requirement_one": "Non-Korean"
          }
        ]
      }
    ],
    "prerequisite": [{ "requirement_one": "Korean RMP" }],
    "detail": [
      {
        "_id": "FT10250019",
        "payout": "70",
        "status": "Not Recruiting",
        "study-type": "Observational",
        "start-date": "01/10/2023",
        "end-date": "04/10/2023",
        "last-updated": "11/15/2021"
      }
    ],
    "location": [
      {
        "address": "1001 Potrero Ave, San Francisco, CA 94110",
        "coordinates": [-122.4591373, 37.7365308]
      }
    ]
  },
  {
    "id": 7,
    "title": "Protonix Treatment of Maintenance of Healing in Pediatric Participants",
    "participants": "Esophagitis",
    "description": "The purpose of this study is to explore the outcomes, tolerability and safety of 2 different doses of oral pantoprazole (full healing dose, half healing dose), assigned based upon weight, for the maintenance of healing of erosive esophagitis in pediatric participants aged 1 to 17 years with endoscopically-confirmed, healed erosive esophagitis.",
    "eligibility": [
      {
        "eligible": [
          {
            "requirement_one": "Esophagitis",
            "requirement_two": "1-17 years",
            "requirement_three": "Gender Neutral"
          }
        ],
        "ineligible": [
          {
            "requirement_one": "Positive oral pantoprazole reaction "
          }
        ]
      }
    ],
    "prerequisite": [
      { "requirement_one": "Negative oral pantoprazole reaction " }
    ],
    "detail": [
      {
        "_id": "FT10250020",
        "payout": "75",
        "status": "Not Recruiting",
        "study-type": "Interventional",
        "start-date": "03/15/2023",
        "end-date": "06/10/2023",
        "last-updated": "11/15/2021"
      }
    ],
    "location": [
      {
        "address": "2356 Sutter St, San Francisco, CA 94115",
        "coordinates": [-122.4415068, 37.7854709]
      }
    ]
  },
  {
    "id": 8,
    "title": "A Study of PF-07258669 In Healthy Adult Participants",
    "participants": "Healthy Participants",
    "description": "Part A of this study is to evaluate safety, tolerability, and pharmacokinetics (PK) of PF-07258669 after administration of multiple ascending oral doses to healthy adult participants.",
    "eligibility": [
      {
        "eligible": [
          {
            "requirement_one": "Healthy",
            "requirement_two": "18-60 years",
            "requirement_three": "Gender Neutral"
          }
        ],
        "ineligible": [
          {
            "requirement_one": "Non-healthy participants "
          }
        ]
      }
    ],
    "prerequisite": [{ "requirement_one": "Must be healthy" }],
    "detail": [
      {
        "_id": "FT10250021",
        "payout": "75",
        "status": "Not Recruiting",
        "study-type": "Interventional",
        "start-date": "02/20/2023",
        "end-date": "08/10/2023",
        "last-updated": "09/15/2021"
      }
    ],
    "location": [
      {
        "address": "2356 Sutter St, San Francisco, CA 94115",
        "coordinates": [-122.4415068, 37.7854709]
      }
    ]
  }
]
